カテゴリー： Allied Market Research, 世界, 医療/バイオ

子宮内避妊器具（IUD）の世界市場2021-2031：機会分析・産業予測

◆英語タイトル：Intrauterine Devices Market By Type (Nonhormonal: Copper-containing IUD, Hormonal: Progestogen-releasing IUD), By Age Group (15-24 years, 25-34 years, 35-44 years, Above 44 years), By End User (Hospitals, Clinics, Community Health Care Centres, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031

Allied Market Researchが発行した調査報告書（ALD22NV0343）◆商品コード：ALD22NV0343
◆発行会社（リサーチ会社）：Allied Market Research
◆発行日：2022年6月
◆ページ数：245
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：グローバル
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single UserUSD5,769 ⇒換算￥842,274見積依頼/購入/質問フォーム
5 UserUSD6,450 ⇒換算￥941,700見積依頼/購入/質問フォーム
Enterprise UserUSD10,995 ⇒換算￥1,605,270見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
Allied Market Research社の本調査資料では、世界の子宮内避妊器具（IUD）市場規模が2021年2,992.73百万ドルから2031年4,374.3百万ドルに達し、2022年から2031年まで年平均3.8％成長すると予測しています。当書は、子宮内避妊器具（IUD）の世界市場を調査対象とし、イントロダクション、エグゼクティブサマリー、市場概要、種類別（ノンホルモン（銅含有IUD）、ホルモン（黄体ホルモン放出IUD））分析、年齢層別（15-24歳、25-34歳、35-44歳、44歳以上）分析、エンドユーザー別（病院、診療所、地域医療センター、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東/アフリカ）分析、企業状況などについて以下の構成でまとめております。なお、参入企業情報として、Bayer AG、CooperSurgical Inc、DKT International、Mona Lisa NV、Pregna International Limited、Prosan International BV、Abviee Inc、Eurogine, S.L.、Viatris Inc、Mona Lisa N.V.,などが含まれております。
・イントロダクション
・エグゼクティブサマリー
・市場概要

・世界の子宮内避妊器具（IUD）市場規模：種類別
- ノンホルモン（銅含有IUD）の市場規模
- ホルモン（黄体ホルモン放出IUD）の市場規模

・世界の子宮内避妊器具（IUD）市場規模：年齢層別
- 15-24歳の市場規模
- 25-34歳の市場規模
- 35-44歳の市場規模
- 44歳以上の市場規模

・世界の子宮内避妊器具（IUD）市場規模：エンドユーザー別
- 病院における市場規模
- 診療所における市場規模
- 地域医療センターにおける市場規模
- その他エンドユーザーにおける市場規模

・世界の子宮内避妊器具（IUD）市場規模：地域別
- 北米の子宮内避妊器具（IUD）市場規模
- ヨーロッパの子宮内避妊器具（IUD）市場規模
- アジア太平洋の子宮内避妊器具（IUD）市場規模
- 中南米の子宮内避妊器具（IUD）市場規模
- 中東/アフリカの子宮内避妊器具（IUD）市場規模

・企業状況
・企業情報
❖ レポートの概要 ❖

The global intrauterine devices market was valued at $2,992.73 million in 2021 and is projected to reach $4,374.3 million by 2031, registering a CAGR of 3.8% from 2022 to 2031.
An intrauterine device (IUD) is a small plastic T-shaped device used for birth control. It is inserted into the uterus where it stays to prevent pregnancy. The intrauterine device is one form of long-acting reversible birth control (LARC) that is also safe and effective in adolescents as well as those who have not previously had children. Once an intrauterine device is removed, even after long-term use, fertility returns to normal rapidly. There are two types of intrauterine devices available on the market including nonhormonal: copper-containing IUD and hormonal: progestogen-releasing IUD to prevent unwanted pregnancies.
The global intrauterine devices market is segmented on the basis of type, age group, end-user, and region. Based on type, the market is classified into nonhormonal: copper-containing IUDs and hormonal: progestogen-releasing IUDs. By age group, it is categorized into 15–24 years, 25–34 years, 35–44 years, and above 44 years. By end-user, it is classified into hospitals, community health centers, clinics, and others. Geographically, it is analyzed across four regions, namely, North America, Europe, Asia-Pacific, and LAMEA.
The major factors that drive the growth of the market are an increase in focus on family planning and the need for preventing unintended pregnancy. The advancement in hormonal intrauterine devices with enhanced efficacy and fewer side effects are expected to further boost the market growth. Moreover, health issues associated with teenage pregnancies, an increase in awareness of intrauterine device methods method to prevent unplanned pregnancy fuel the market growth. However, health risks associated with the use of contraceptives, and lack of social acceptance adversely affect the market growth.
The key players operating in the global intrauterine devices market include the AbbVie Inc.(Allergan Plc) , Bayer AG, Cooper Companies Inc, DKT International, Mona Lisa NV ( EurimPharma Group) , Ocon Healthcare, Pregana International Ltd, Prosan International B.V. Eurogine SL and Viatris Inc. (Mylan NV).
In 2021, Asia Pacific was the major revenue generator, owing to the presence of a large population, increase in awareness of the benefits of using hormonal intrauterine devices, high prevalence of unwanted pregnancy, and favorable regulatory scenario. However, North America is the second-largest revenue generator in 2021, due to the presence of. healthcare infrastructure and rising awareness pertaining to the usage of IUDs.
 
Key Benefits For Stakeholders
●This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the intrauterine devices market analysis from 2021 to 2031 to identify the prevailing intrauterine devices market opportunities.
●Market research is offered along with information related to key drivers, restraints, and opportunities.
●Porter’s five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
●In-depth analysis of the intrauterine devices market segmentation assists to determine the prevailing market opportunities.
●Major countries in each region are mapped according to their revenue contribution to the global market.
●Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
●The report includes the analysis of the regional as well as global intrauterine devices market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Type
● Nonhormonal: Copper-containing IUD
● Hormonal: Progestogen-releasing IUD

By Age Group
● 25-34 years
● 35-44 years
● Above 44 years
● 15-24 years

By End User
● Hospitals
● Clinics
● Community Health Care Centres
● Others

By Region
● North America
○ U.S.
○ Canada
○ Mexico
● Europe
○ Germany
○ France
○ U.K.
○ Italy
○ Spain
○ Rest of Europe
● Asia-Pacific
○ Japan
○ China
○ Australia
○ India
○ South Korea
○ Rest Of Asia Pacific
● LAMEA
○ Brazil
○ Saudi Arabia
○ South Africa
○ Rest of LAMEA

Key Market Players
○ Bayer AG
○ CooperSurgical Inc
○ DKT International
○ Mona Lisa NV
○ Pregna International Limited
○ Prosan International BV
○ Abviee Inc
○ Eurogine, S.L.
○ Viatris Inc
○ Mona Lisa N.V.,

❖ レポートの目次 ❖

CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: INTRAUTERINE DEVICES MARKET, BY TYPE
4.1 Overview
4.1.1 Market size and forecast
4.2 Nonhormonal: Copper-containing IUD
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Hormonal: Progestogen-releasing IUD
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
CHAPTER 5: INTRAUTERINE DEVICES MARKET, BY AGE GROUP
5.1 Overview
5.1.1 Market size and forecast
5.2 15-24 years
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 25-34 years
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 35-44 years
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
5.5 Above 44 years
5.5.1 Key market trends, growth factors and opportunities
5.5.2 Market size and forecast, by region
5.5.3 Market analysis by country
CHAPTER 6: INTRAUTERINE DEVICES MARKET, BY END USER
6.1 Overview
6.1.1 Market size and forecast
6.2 Hospitals
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Clinics
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
6.4 Community Health Care Centres
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market analysis by country
6.5 Others
6.5.1 Key market trends, growth factors and opportunities
6.5.2 Market size and forecast, by region
6.5.3 Market analysis by country
CHAPTER 7: INTRAUTERINE DEVICES MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Type
7.2.3 North America Market size and forecast, by Age Group
7.2.4 North America Market size and forecast, by End User
7.2.5 North America Market size and forecast, by country
7.2.5.1 U.S.
7.2.5.1.1 Market size and forecast, by Type
7.2.5.1.2 Market size and forecast, by Age Group
7.2.5.1.3 Market size and forecast, by End User
7.2.5.2 Canada
7.2.5.2.1 Market size and forecast, by Type
7.2.5.2.2 Market size and forecast, by Age Group
7.2.5.2.3 Market size and forecast, by End User
7.2.5.3 Mexico
7.2.5.3.1 Market size and forecast, by Type
7.2.5.3.2 Market size and forecast, by Age Group
7.2.5.3.3 Market size and forecast, by End User
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Type
7.3.3 Europe Market size and forecast, by Age Group
7.3.4 Europe Market size and forecast, by End User
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Market size and forecast, by Type
7.3.5.1.2 Market size and forecast, by Age Group
7.3.5.1.3 Market size and forecast, by End User
7.3.5.2 France
7.3.5.2.1 Market size and forecast, by Type
7.3.5.2.2 Market size and forecast, by Age Group
7.3.5.2.3 Market size and forecast, by End User
7.3.5.3 U.K.
7.3.5.3.1 Market size and forecast, by Type
7.3.5.3.2 Market size and forecast, by Age Group
7.3.5.3.3 Market size and forecast, by End User
7.3.5.4 Italy
7.3.5.4.1 Market size and forecast, by Type
7.3.5.4.2 Market size and forecast, by Age Group
7.3.5.4.3 Market size and forecast, by End User
7.3.5.5 Spain
7.3.5.5.1 Market size and forecast, by Type
7.3.5.5.2 Market size and forecast, by Age Group
7.3.5.5.3 Market size and forecast, by End User
7.3.5.6 Rest of Europe
7.3.5.6.1 Market size and forecast, by Type
7.3.5.6.2 Market size and forecast, by Age Group
7.3.5.6.3 Market size and forecast, by End User
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Type
7.4.3 Asia-Pacific Market size and forecast, by Age Group
7.4.4 Asia-Pacific Market size and forecast, by End User
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 Japan
7.4.5.1.1 Market size and forecast, by Type
7.4.5.1.2 Market size and forecast, by Age Group
7.4.5.1.3 Market size and forecast, by End User
7.4.5.2 China
7.4.5.2.1 Market size and forecast, by Type
7.4.5.2.2 Market size and forecast, by Age Group
7.4.5.2.3 Market size and forecast, by End User
7.4.5.3 Australia
7.4.5.3.1 Market size and forecast, by Type
7.4.5.3.2 Market size and forecast, by Age Group
7.4.5.3.3 Market size and forecast, by End User
7.4.5.4 India
7.4.5.4.1 Market size and forecast, by Type
7.4.5.4.2 Market size and forecast, by Age Group
7.4.5.4.3 Market size and forecast, by End User
7.4.5.5 South Korea
7.4.5.5.1 Market size and forecast, by Type
7.4.5.5.2 Market size and forecast, by Age Group
7.4.5.5.3 Market size and forecast, by End User
7.4.5.6 Rest Of Asia Pacific
7.4.5.6.1 Market size and forecast, by Type
7.4.5.6.2 Market size and forecast, by Age Group
7.4.5.6.3 Market size and forecast, by End User
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Type
7.5.3 LAMEA Market size and forecast, by Age Group
7.5.4 LAMEA Market size and forecast, by End User
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Brazil
7.5.5.1.1 Market size and forecast, by Type
7.5.5.1.2 Market size and forecast, by Age Group
7.5.5.1.3 Market size and forecast, by End User
7.5.5.2 Saudi Arabia
7.5.5.2.1 Market size and forecast, by Type
7.5.5.2.2 Market size and forecast, by Age Group
7.5.5.2.3 Market size and forecast, by End User
7.5.5.3 South Africa
7.5.5.3.1 Market size and forecast, by Type
7.5.5.3.2 Market size and forecast, by Age Group
7.5.5.3.3 Market size and forecast, by End User
7.5.5.4 Rest of LAMEA
7.5.5.4.1 Market size and forecast, by Type
7.5.5.4.2 Market size and forecast, by Age Group
7.5.5.4.3 Market size and forecast, by End User
CHAPTER 8: COMPANY LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments
CHAPTER 9: COMPANY PROFILES
9.1 Bayer AG
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Product portfolio
9.1.5 Business performance
9.1.6 Key strategic moves and developments
9.2 CooperSurgical Inc
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Product portfolio
9.2.5 Business performance
9.2.6 Key strategic moves and developments
9.3 DKT International
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Product portfolio
9.3.5 Business performance
9.3.6 Key strategic moves and developments
9.4 Mona Lisa NV
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Product portfolio
9.4.5 Business performance
9.4.6 Key strategic moves and developments
9.5 Pregna International Limited
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Product portfolio
9.5.5 Business performance
9.5.6 Key strategic moves and developments
9.6 Prosan International BV
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Product portfolio
9.6.5 Business performance
9.6.6 Key strategic moves and developments
9.7 Abviee Inc
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Product portfolio
9.7.5 Business performance
9.7.6 Key strategic moves and developments
9.8 Eurogine, S.L.
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Product portfolio
9.8.5 Business performance
9.8.6 Key strategic moves and developments
9.9 Viatris Inc
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Product portfolio
9.9.5 Business performance
9.9.6 Key strategic moves and developments
9.10 Mona Lisa N.V.,
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Operating business segments
9.10.4 Product portfolio
9.10.5 Business performance
9.10.6 Key strategic moves and developments



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 子宮内避妊器具（IUD）の世界市場2021-2031：機会分析・産業予測(Intrauterine Devices Market By Type (Nonhormonal: Copper-containing IUD, Hormonal: Progestogen-releasing IUD), By Age Group (15-24 years, 25-34 years, 35-44 years, Above 44 years), By End User (Hospitals, Clinics, Community Health Care Centres, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • ガスクロマトグラフィー（GC）の世界市場2021-2031：機会分析・産業予測
    ALD22AU147 / Allied Market Research / 2022年5月 / Allied Market Research社の当調査資料では、世界のガスクロマトグラフィー（GC）市場を対象に総合的に調査・分析を行い、イントロダクション、エグゼクティブサマリー、市場概要、製品別（機器、消耗品、付属品）分析、エンドユーザー別（製薬＆バイオテクノロジー企業、学術＆研究機関、食品＆飲料メーカー、その他）分析、地域別分析、企業状況、企業情報などの項目をまとめております。なお、当書に掲載されている企業情報には、Agilent...
  • 免疫組織化学的検査（IHC）の世界市場2021-2031：機会分析・産業予測
    ALD22NV0327 / Allied Market Research / 2022年7月 / Allied Market Research社の本調査資料では、世界の免疫組織化学的検査（IHC）市場規模が2021年2,388.5百万ドルから2031年4,530.56百万ドルに達し、2022年から2031年まで年平均6.5％成長すると予測しています。当書は、免疫組織化学的検査（IHC）の世界市場を調査対象とし、イントロダクション、エグゼクティブサマリー、市場概要、製品別（抗体、試薬、キット、装置）分析、用途別（診断、研究、科学捜査）分析、エンドユーザー別（病院＆診断所、研究＆学術機関、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東/アフリカ）分析、企業状況などについて以下の構成でまとめております。なお、参入企業情報として、Agilent...
  • カイフォプラスティ（後弯術）の世界市場2021-2031：機会分析・産業予測
    ALD22NV0348 / Allied Market Research / 2022年6月 / Allied Market Research社の本調査資料では、世界のカイフォプラスティ（後弯術）市場規模が2021年632.45百万ドルから2031年1,154.82百万ドルに達し、2022年から2031年まで年平均6.2％成長すると予測しています。当書は、カイフォプラスティ（後弯術）の世界市場を調査対象とし、イントロダクション、エグゼクティブサマリー、市場概要、製品別（骨粗鬆症治療器、付属品）分析、疾患別（骨粗鬆症、その他）分析、エンドユーザー別（病院＆診療所、外来手術センター）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東/アフリカ）分析、企業状況などについて以下の構成でまとめております。なお、参入企業情報として、Alphatec...
  • 眼内レンズ（IOL）の世界市場2021-2031：機会分析・産業予測
    ALD22AU171 / Allied Market Research / 2022年5月 / Allied Market Research社は、2021年に3,777.16百万ドルであった世界の眼内レンズ（IOL）市場が、2022年から2031年まで年平均5.6％成長し、2031年までに6,535.51百万ドルに達すると予測しています。当書では、眼内レンズ（IOL）の世界市場を対象に総合的に調査・分析を行い、イントロダクション、エグゼクティブサマリー、市場概要、種類別（単焦点眼内レンズ、高級眼内レンズ）分析、素材別（ポリメチルメタクリレート、シリコン、疎水性＆親水性アクリル素材）分析、エンドユーザー別（病院、外来手術センター、眼科クリニック、眼科研究機関）分析、地域別分析、企業状況、企業情報などの項目をまとめております。なお、当書に掲載されている企業情報には、Alcon、Bausch...
  • フローリング（床材）の世界市場2021-2031：機会分析・産業予測
    ALD22NV0279 / Allied Market Research / 2022年8月 / Allied Market Research社の本調査資料では、世界のフローリング（床材）市場規模が2021年320,289百万ドルから2031年558,208百万ドルに達し、2022年から2031年まで年平均5.6％成長すると予測しています。当書は、フローリング（床材）の世界市場を調査対象とし、イントロダクション、エグゼクティブサマリー、市場概要、印刷タイプ別（デジタル、従来型）分析、素材別（木材、石材、セラミック、ラミネート、その他）分析、エンドユーザー別（住宅、非住宅）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東/アフリカ）分析、企業状況などについて以下の構成でまとめております。なお、参入企業情報として、ARMSTRONG...

    • ◆H&Iグローバルリサーチのお客様（例）◆